United States ex rel. Camburn v. Novartis Pharmaceuticals Corp.
The Second Circuit established that a False Claims Act claim based on an Anti-Kickback Statute violation requires alleging that at least one purpose of the remuneration was to induce fraudulent conduct. The court partially affirmed the dismissal of the complaint, allowing specific allegations regarding sham speaker events and excessive compensation to proceed while rejecting other claims for insufficient particularity.